Advaxis Inc. Stock
Advaxis Inc. Stock
So far the community has only identified positive things for Advaxis Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Advaxis Inc. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Advaxis Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Advaxis Inc. | - | - | - | - | - | - | - |
| Beximco Pharmaceuticals Ltd. GDR | 2.130% | 5.727% | 6.667% | 15.942% | 15.385% | -20.661% | -42.857% |
| SELLAS Life Sciences Group Inc | 3.130% | 15.600% | 35.257% | 112.761% | 84.272% | -27.265% | -74.884% |
| Eledon Pharmaceuticals Inc. | 13.850% | 11.278% | -1.333% | -65.899% | -63.725% | -33.929% | -90.976% |
Comments
Ayala Pharmaceuticals, Inc. (NASDAQ: ADXS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ADXS provided by MarketBeat
Ayala Pharmaceuticals, Inc. (NASDAQ: ADXS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ADXS provided by MarketBeat
Ayala Pharmaceuticals, Inc. (NASDAQ: ADXS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ADXS provided by MarketBeat